We utilized the rabbit model of aortic valve infective endocarditis to examine the combined efficacy of the lysin LSVT-1701 plus daptomycin. The combination of LSVT-1701 plus daptomycin was highly effective at reducing methicillin-resistant Staphylococcus aureus (MRSA) counts in target tissue. When given for four daily doses, both lysin dose regimens in combination with daptomycin sterilized all target tissues. These findings suggest that LSVT-1701 warrants further clinical evaluation as an adjunctive therapy for the treatment of invasive MRSA infections.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8284455PMC
http://dx.doi.org/10.1128/AAC.00508-21DOI Listing

Publication Analysis

Top Keywords

lysin lsvt-1701
8
combination daptomycin
8
infective endocarditis
8
methicillin-resistant staphylococcus
8
staphylococcus aureus
8
lsvt-1701 daptomycin
8
efficacy antistaphylococcal
4
antistaphylococcal lysin
4
lsvt-1701
4
lsvt-1701 combination
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!